KODMID

Kodiak Sciences Inc.

HealthcareBiotechnology
$43.68
$0.02(-4.82%)
52W$2.81
$47.84
Updated May 8, 12:00 AM
RSI62
RS Rating97/99
Beta1.81
Volatility141%
F-Score3/9
Mkt Cap$2.3B
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Kodiak Sciences Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 97), indicating clear outperformance against the broad market. Earnings contraction of 38% provides fundamental context to the price action. However, price is extended 24% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
97
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
1.81
vs S&P 500
HIGH BETA
52W Position
91%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$35.32
50 SMA > 100 SMA$30.57
100 SMA > 150 SMA$26.66
150 SMA > 200 SMA$22.49

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$44.02-0.77%BELOW
50 SMA$35.32+23.66%ABOVE
100 SMA$30.57+42.89%ABOVE
150 SMA$26.66+63.81%ABOVE
200 SMA$22.49+94.21%ABOVE

Price Performance

1D-4.8%
1W+0.5%
1M+4.5%
3M+79.8%
6M+147.8%
YTD+67.9%
1Y+10.3%
3Y+107.8%
52-Week Trading Range91% from low
$43.68
52W Low$2.81
52W High$47.84

Technical Indicators

RSI (14)BULLISH
61.7
305070
VCP ScoreWARM
6/10
Base depth: 61.5%

Risk Profile

Beta
1.81
52W Vol
141%
ATR
$3.06
Max DD (1Y)
-32%

Volume Analysis

Today
361.7K
50D Avg
1.14M
Vol Ratio
0.32x
Liquidity
MODERATE

Earnings Momentum

Q4'24+26%
$-0.84
Q1'25-33%
$-1.09
Q2'25-20%
$-1.03
Q3'25-38%
$-1.16
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-12.88%

Stock Price CAGR

10 Years:+35.92%
5 Years:+16.54%
3 Years:+107.77%
1 Year:+10.29%

Return on Equity

10Y Avg:-108.1%
5Y Avg:-55.4%
3Y Avg:-73.2%
Last Year:-917.3%

Key Metrics

Market Cap$2.3B
Gross Margin
Net Margin
Piotroski F-Score3/9

Frequently Asked Questions

Is KOD in an uptrend right now?

KOD has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, KOD is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is KOD overbought or oversold?

KOD's RSI (14) is 62. The stock is in neutral territory, neither overbought nor oversold.

Is KOD outperforming the market?

KOD has a Relative Strength (RS) Rating of 97 out of 99. Yes, KOD is a market leader, outperforming 97% of all stocks over the past 12 months.

Where is KOD in its 52-week range?

KOD is trading at $43.68, which is 91% of its 52-week high ($47.84) and 91% above its 52-week low ($2.81).

How volatile is KOD?

KOD has a Beta of 1.81 and 52-week volatility of 141%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.